![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 401/04 | (2006.01) |
A61K 31/4439 | (2006.01) | ||
A61P 1/04 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3102208 |
(13) | Kind of document | T |
(96) | European patent application number | 15746995.8 |
Date of filing the European patent application | 2015-02-05 | |
(97) | Date of publication of the European application | 2016-12-14 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
(46) | Date of publication of the claims translation | 2021-05-10 |
(86) | Number | PCT/US2015/014589 |
Date | 2015-02-05 |
(87) | Number | WO 2015/120133 |
Date | 2015-08-13 |
(30) | Number | Date | Country code |
201461937393 P | 2014-02-07 | US | |
201461937404 P | 2014-02-07 | US |
(72) |
LI, Zhe, US
PARENT, Stephan D., US
HOUSTON, Travis, US
|
(73) |
Global Blood Therapeutics, Inc.,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoksi)benzaldehido laisvos bazės kristalinis polimorfas |
CRYSTALLINE POLYMORPH OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE |
Payment date | Validity (years) | Amount | |
2025-01-17 | 11 | 289.00 EUR |
2026-02-05 |